CFLAR Human (-)-alpha-phellandrene increases expression EXP 6480464 alpha phellandrene results in increased expression of CFLAR mRNA CTD PMID:25075043 CFLAR Human (-)-demecolcine increases expression EXP 6480464 Demecolcine results in increased expression of CFLAR mRNA CTD PMID:23649840 CFLAR Human (-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CFLAR mRNA CTD PMID:22079256 CFLAR Human (1->4)-beta-D-glucan multiple interactions ISO Cflar (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CFLAR mRNA CTD PMID:36331819 CFLAR Human 1'-acetoxychavicol acetate multiple interactions EXP 6480464 1'-acetoxychavicol acetate inhibits the reaction [TNF protein results in increased expression of CFLAR protein] CTD PMID:15905586 CFLAR Human 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases expression ISO Cflar (Rattus norvegicus) 6480464 o and p'-DDT analog results in decreased expression of CFLAR mRNA CTD PMID:22937105 CFLAR Human 1,1-dichloroethene decreases expression ISO Cflar (Mus musculus) 6480464 vinylidene chloride results in decreased expression of CFLAR mRNA CTD PMID:26682919 CFLAR Human 1,2-dimethylhydrazine multiple interactions ISO Cflar (Mus musculus) 6480464 Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of CFLAR mRNA] CTD PMID:22206623 CFLAR Human 1,2-dimethylhydrazine decreases expression ISO Cflar (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of CFLAR mRNA CTD PMID:22206623 CFLAR Human 1,3-dinitrobenzene increases expression ISO Cflar (Rattus norvegicus) 6480464 3-dinitrobenzene results in increased expression of CFLAR mRNA CTD PMID:22841810 CFLAR Human 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases expression ISO Cflar (Mus musculus) 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:15329391 CFLAR Human 15-deoxy-Delta(12,14)-prostaglandin J2 decreases expression EXP 6480464 15-deoxy-delta(12 and 14)-prostaglandin J2 results in decreased expression of CFLAR protein CTD PMID:15498850 CFLAR Human 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of CFLAR mRNA CTD PMID:21826169 CFLAR Human 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO Cflar (Rattus norvegicus) 6480464 2 more ... CTD PMID:27291303 CFLAR Human 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:27589474 CFLAR Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Cflar (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CFLAR mRNA CTD PMID:12167310 CFLAR Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CFLAR mRNA CTD PMID:31536130 CFLAR Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Cflar (Mus musculus) 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of CFLAR mRNA CTD PMID:25975270 CFLAR Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Cflar (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of CFLAR mRNA CTD PMID:22298810 CFLAR Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Cflar (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CFLAR mRNA CTD PMID:19520675 CFLAR Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Cflar (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CFLAR mRNA and Tetrachlorodibenzodioxin results in decreased expression of CFLAR protein CTD PMID:18334599 CFLAR Human 2,4-dinitrotoluene affects expression ISO Cflar (Rattus norvegicus) 6480464 2 and 4-dinitrotoluene affects the expression of CFLAR mRNA CTD PMID:21346803 CFLAR Human 2-amino-2-deoxy-D-galactopyranose multiple interactions ISO Cflar (Mus musculus) 6480464 [Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of CFLAR protein more ... CTD PMID:20850421 CFLAR Human 2-Hydroxy-6-(8,11,14-pentadecatrienyl)benzoic acid multiple interactions EXP 6480464 anacardic acid inhibits the reaction [TNF protein results in increased expression of CFLAR protein] CTD PMID:18349320 CFLAR Human 3,4-methylenedioxymethamphetamine increases expression ISO Cflar (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of CFLAR mRNA CTD PMID:20188158 CFLAR Human 3,4-methylenedioxymethamphetamine decreases expression ISO Cflar (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of CFLAR mRNA CTD PMID:26251327 CFLAR Human 3-chloropropane-1,2-diol increases expression ISO Cflar (Rattus norvegicus) 6480464 alpha-Chlorohydrin results in increased expression of CFLAR protein CTD PMID:34915118 CFLAR Human 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CFLAR mRNA CTD PMID:28628672 CFLAR Human 4,4'-diaminodiphenylmethane increases expression ISO Cflar (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of CFLAR mRNA CTD PMID:18648102 CFLAR Human 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CFLAR mRNA CTD PMID:28628672 CFLAR Human 4,4'-sulfonyldiphenol multiple interactions ISO Cflar (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CFLAR mRNA CTD PMID:36041667 CFLAR Human 4-(4-chloro-2-methylphenoxy)-N-hydroxybutanamide decreases expression EXP 6480464 4-(4-chloro-2-methylphenoxy)-N-hydroxybutanamide results in decreased expression of CFLAR mRNA and 4-(4-chloro-2-methylphenoxy)-N-hydroxybutanamide results in decreased expression of CFLAR protein CTD PMID:20446019 CFLAR Human 4-hydroxyphenyl retinamide multiple interactions EXP 6480464 Fenretinide inhibits the reaction [TNF protein results in increased expression of CFLAR protein] CTD PMID:16230421 CFLAR Human 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of CFLAR protein CTD PMID:16230421 CFLAR Human 4-nitrophenol decreases expression ISO Cflar (Mus musculus) 6480464 4-nitrophenol results in decreased expression of CFLAR mRNA CTD PMID:34673133 CFLAR Human 5-aza-2'-deoxycytidine affects expression EXP 6480464 Decitabine affects the expression of CFLAR protein CTD PMID:18636160 CFLAR Human 5-fluorouracil multiple interactions EXP 6480464 [Fluorouracil co-treated with IFNA1 protein] results in decreased expression of CFLAR protein more ... CTD PMID:16373718 more ... CFLAR Human 5-fluorouracil affects response to substance EXP 6480464 CFLAR protein affects the susceptibility to Fluorouracil CTD PMID:15548681 more ... CFLAR Human 5-fluorouracil decreases expression EXP 6480464 Fluorouracil results in decreased expression of CFLAR mRNA and Fluorouracil results in decreased expression of CFLAR protein CTD PMID:16373718 more ... CFLAR Human 5-fluorouracil increases expression EXP 6480464 Fluorouracil results in increased expression of CFLAR mRNA CTD PMID:15152939 CFLAR Human 6-propyl-2-thiouracil increases expression ISO Cflar (Rattus norvegicus) 6480464 Propylthiouracil results in increased expression of CFLAR mRNA CTD PMID:24780913 CFLAR Human 8-Br-cAMP multiple interactions EXP 6480464 [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CFLAR protein alternative form CTD PMID:16709600 CFLAR Human [6]-Shogaol multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in decreased expression of CFLAR protein modified form]] more ... CTD PMID:25619640 CFLAR Human [6]-Shogaol decreases expression EXP 6480464 shogaol results in decreased expression of CFLAR protein modified form CTD PMID:25619640 CFLAR Human acetylsalicylic acid increases expression EXP 6480464 Aspirin results in increased expression of CFLAR mRNA CTD PMID:20457246 CFLAR Human acetylsalicylic acid multiple interactions ISO Cflar (Mus musculus) 6480464 Aspirin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CFLAR protein] CTD PMID:25449198 CFLAR Human acrolein multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of CFLAR mRNA CTD PMID:32845096 CFLAR Human acrylamide decreases expression ISO Cflar (Rattus norvegicus) 6480464 Acrylamide results in decreased expression of CFLAR mRNA CTD PMID:28959563 CFLAR Human actinomycin D decreases expression EXP 6480464 Dactinomycin results in decreased expression of CFLAR protein CTD PMID:11234897 and PMID:14601052 CFLAR Human adenosine decreases expression EXP 6480464 Adenosine results in decreased expression of CFLAR mRNA more ... CTD PMID:17303086 CFLAR Human adenosine multiple interactions EXP 6480464 Dipyridamole inhibits the reaction [Adenosine results in decreased expression of CFLAR mRNA alternative form] more ... CTD PMID:17303086 CFLAR Human aflatoxin B1 increases expression ISO Cflar (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of CFLAR mRNA CTD PMID:19770486 CFLAR Human aflatoxin B1 increases methylation EXP 6480464 Aflatoxin B1 results in increased methylation of CFLAR gene CTD PMID:28458013 CFLAR Human all-trans-retinoic acid multiple interactions EXP 6480464 [Tretinoin co-treated with TGFB1 protein] results in increased expression of CFLAR protein and Tretinoin promotes the reaction [rosiglitazone results in decreased expression of CFLAR mRNA] CTD PMID:16242776 more ... CFLAR Human all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of CFLAR mRNA CTD PMID:21934132 and PMID:33167477 CFLAR Human alpha-phellandrene increases expression EXP 6480464 alpha phellandrene results in increased expression of CFLAR mRNA CTD PMID:25075043 CFLAR Human alvocidib multiple interactions EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [alvocidib results in decreased expression of CFLAR protein] CTD PMID:16951203 CFLAR Human alvocidib decreases expression EXP 6480464 alvocidib results in decreased expression of CFLAR and alvocidib results in decreased expression of CFLAR protein CTD PMID:16820931 and PMID:16951203 CFLAR Human alvocidib affects expression EXP 6480464 alvocidib affects the expression of CFLAR mRNA CTD PMID:16951203 CFLAR Human amiodarone decreases expression ISO Cflar (Rattus norvegicus) 6480464 Amiodarone results in decreased expression of CFLAR protein CTD PMID:21224497 CFLAR Human amitrole decreases expression ISO Cflar (Rattus norvegicus) 6480464 Amitrole results in decreased expression of CFLAR mRNA CTD PMID:38685447 CFLAR Human ammonium chloride affects expression ISO Cflar (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of CFLAR mRNA CTD PMID:16483693 CFLAR Human antirheumatic drug decreases expression EXP 6480464 Antirheumatic Agents results in decreased expression of CFLAR mRNA CTD PMID:17696278 CFLAR Human antirheumatic drug increases expression EXP 6480464 Antirheumatic Agents results in increased expression of CFLAR mRNA CTD PMID:24449571 CFLAR Human aristolochic acid A multiple interactions ISO Cflar (Rattus norvegicus) 6480464 [aristolochic acid I co-treated with aristolochic acid II] results in increased expression of CFLAR mRNA CTD PMID:23912714 CFLAR Human aristolochic acid A increases expression EXP 6480464 aristolochic acid I results in increased expression of CFLAR mRNA CTD PMID:33212167 CFLAR Human arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of CFLAR mRNA CTD PMID:22521957 CFLAR Human arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of CFLAR mRNA more ... CTD PMID:16105982 more ... CFLAR Human arsenous acid decreases response to substance EXP 6480464 CFLAR protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:16105982 CFLAR Human arsenous acid multiple interactions EXP 6480464 [Arsenic Trioxide co-treated with TNF protein] results in decreased expression of CFLAR protein more ... CTD PMID:17673311 and PMID:23082001 CFLAR Human Azoxymethane multiple interactions ISO Cflar (Mus musculus) 6480464 [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CFLAR protein more ... CTD PMID:25449198 CFLAR Human baicalein multiple interactions ISO Cflar (Mus musculus) 6480464 baicalein inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of CFLAR protein] CTD PMID:20850421 CFLAR Human beauvericin increases expression EXP 6480464 beauvericin results in increased expression of CFLAR mRNA CTD PMID:29203277 CFLAR Human benzo[a]pyrene multiple interactions ISO Cflar (Mus musculus) 6480464 AHR protein promotes the reaction [Benzo(a)pyrene results in decreased expression of CFLAR mRNA] CTD PMID:15034205 CFLAR Human benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of CFLAR promoter CTD PMID:27901495 CFLAR Human benzo[a]pyrene affects methylation EXP 6480464 Benzo(a)pyrene affects the methylation of CFLAR 5' UTR CTD PMID:27901495 CFLAR Human benzo[a]pyrene decreases expression ISO Cflar (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of CFLAR mRNA CTD PMID:15034205 CFLAR Human beta-carotene increases expression EXP 6480464 beta Carotene results in increased expression of CFLAR mRNA CTD PMID:17034753 CFLAR Human beta-lapachone increases expression EXP 6480464 beta-lapachone results in increased expression of CFLAR mRNA CTD PMID:38218311 CFLAR Human bis(2-ethylhexyl) phthalate decreases expression ISO Cflar (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of CFLAR mRNA CTD PMID:19850644 CFLAR Human bis(2-ethylhexyl) phthalate multiple interactions ISO Cflar (Mus musculus) 6480464 PPARA protein inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of CFLAR mRNA] CTD PMID:19850644 CFLAR Human bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CFLAR mRNA CTD PMID:21826169 CFLAR Human bisphenol A multiple interactions ISO Cflar (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CFLAR mRNA CTD PMID:36041667 CFLAR Human bisphenol A decreases expression ISO Cflar (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of CFLAR mRNA CTD PMID:32145629 and PMID:34947998 CFLAR Human bisphenol A affects expression ISO Cflar (Rattus norvegicus) 6480464 bisphenol A affects the expression of CFLAR mRNA CTD PMID:25181051 CFLAR Human bisphenol A increases expression ISO Cflar (Mus musculus) 6480464 bisphenol A results in increased expression of CFLAR mRNA CTD PMID:22687993 CFLAR Human bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CFLAR mRNA CTD PMID:20678512 and PMID:29275510 CFLAR Human bisphenol F increases expression ISO Cflar (Mus musculus) 6480464 bisphenol F results in increased expression of CFLAR mRNA CTD PMID:38685157 CFLAR Human bisphenol F multiple interactions ISO Cflar (Rattus norvegicus) 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CFLAR mRNA CTD PMID:36041667 CFLAR Human bortezomib multiple interactions EXP 6480464 [Bortezomib co-treated with TNFSF10 protein] results in decreased expression of CFLAR protein more ... CTD PMID:17659339 more ... CFLAR Human bortezomib decreases response to substance EXP 6480464 CFLAR protein alternative form results in decreased susceptibility to Bortezomib and CFLAR results in decreased susceptibility to Bortezomib CTD PMID:17510429 CFLAR Human bortezomib decreases expression EXP 6480464 Bortezomib results in decreased expression of CFLAR mRNA and Bortezomib results in decreased expression of CFLAR protein CTD PMID:17327374 more ... CFLAR Human bortezomib increases expression EXP 6480464 Bortezomib results in increased expression of CFLAR protein more ... CTD PMID:17351739 more ... CFLAR Human bortezomib affects expression EXP 6480464 Bortezomib affects the expression of CFLAR protein CTD PMID:17326159 CFLAR Human butanal decreases expression EXP 6480464 butyraldehyde results in decreased expression of CFLAR mRNA CTD PMID:26079696 CFLAR Human cadmium dichloride increases expression ISO Cflar (Rattus norvegicus) 6480464 Cadmium Chloride results in increased expression of CFLAR mRNA CTD PMID:19010381 CFLAR Human cafestol decreases expression EXP 6480464 cafestol results in decreased expression of CFLAR protein CTD PMID:21334318 CFLAR Human camptothecin multiple interactions ISO Cflar (Mus musculus) 6480464 Camptothecin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CFLAR protein] CTD PMID:25449198 CFLAR Human cannabidiol increases expression ISO Cflar (Mus musculus) 6480464 Cannabidiol results in increased expression of CFLAR mRNA CTD PMID:30742662 CFLAR Human cannabidiol multiple interactions EXP 6480464 [Cannabidiol co-treated with moringin] results in decreased expression of CFLAR mRNA and [PSEN1 protein affects the susceptibility to Cannabidiol] which affects the expression of CFLAR mRNA CTD PMID:30096889 and PMID:33096116 CFLAR Human capsaicin decreases expression EXP 6480464 Capsaicin results in decreased expression of CFLAR protein alternative form CTD PMID:19939880 CFLAR Human capsaicin increases expression EXP 6480464 Capsaicin results in increased expression of CFLAR mRNA CTD PMID:19502594 CFLAR Human carbamazepine affects expression EXP 6480464 Carbamazepine affects the expression of CFLAR mRNA CTD PMID:24752500 CFLAR Human carbon nanotube increases expression ISO Cflar (Mus musculus) 6480464 Nanotubes and Carbon results in increased expression of CFLAR mRNA CTD PMID:25554681 and PMID:25620056 CFLAR Human Cardanol decreases expression EXP 6480464 cardanol results in decreased expression of CFLAR mRNA CTD PMID:26694491 CFLAR Human celecoxib decreases expression EXP 6480464 Celecoxib results in decreased expression of CFLAR CTD PMID:17145853 CFLAR Human choline multiple interactions ISO Cflar (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CFLAR gene CTD PMID:20938992 CFLAR Human ciguatoxin CTX1B affects expression ISO Cflar (Mus musculus) 6480464 Ciguatoxins affects the expression of CFLAR mRNA CTD PMID:18353800 CFLAR Human cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of CFLAR protein CTD PMID:14601052 and PMID:20876774 CFLAR Human cisplatin multiple interactions EXP 6480464 [Cisplatin results in decreased expression of CFLAR protein] which results in increased susceptibility to TNFSF10 protein and [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of CFLAR mRNA CTD PMID:20876774 and PMID:30871063 CFLAR Human cisplatin decreases response to substance ISO Cflar (Mus musculus) 6480464 CFLAR protein results in decreased susceptibility to Cisplatin CTD PMID:20683665 CFLAR Human clofibrate decreases expression ISO Cflar (Mus musculus) 6480464 Clofibrate results in decreased expression of CFLAR mRNA CTD PMID:23811191 CFLAR Human cobalt dichloride multiple interactions EXP 6480464 lysophosphatidylethanolamine analog inhibits the reaction [cobaltous chloride results in decreased expression of CFLAR mRNA] CTD PMID:25125499 CFLAR Human cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of CFLAR mRNA CTD PMID:25125499 CFLAR Human cocaine affects expression ISO Cflar (Mus musculus) 6480464 Cocaine affects the expression of CFLAR mRNA CTD PMID:15681117 CFLAR Human copper atom multiple interactions EXP 6480464 [Chelating Agents binds to Copper] which results in increased expression of CFLAR mRNA CTD PMID:30911355 CFLAR Human copper(0) multiple interactions EXP 6480464 [Chelating Agents binds to Copper] which results in increased expression of CFLAR mRNA CTD PMID:30911355 CFLAR Human coumestrol decreases expression EXP 6480464 Coumestrol results in decreased expression of CFLAR mRNA CTD PMID:19167446 CFLAR Human crocidolite asbestos decreases expression ISO Cflar (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of CFLAR mRNA CTD PMID:29279043 CFLAR Human Cuprizon decreases expression ISO Cflar (Rattus norvegicus) 6480464 Cuprizone results in decreased expression of CFLAR mRNA CTD PMID:26577399 CFLAR Human Cuprizon increases expression ISO Cflar (Rattus norvegicus) 6480464 Cuprizone results in increased expression of CFLAR mRNA CTD PMID:27523638 CFLAR Human curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of CFLAR mRNA] and Curcumin inhibits the reaction [TNF protein results in increased expression of CFLAR mRNA] CTD PMID:16219905 and PMID:23452621 CFLAR Human curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of CFLAR protein CTD PMID:16173963 CFLAR Human cycloheximide decreases expression EXP 6480464 Cycloheximide results in decreased expression of CFLAR protein more ... CTD PMID:12663669 more ... CFLAR Human cycloheximide multiple interactions EXP 6480464 shogaol promotes the reaction [Cycloheximide results in decreased expression of CFLAR protein modified form] CTD PMID:25619640 CFLAR Human deguelin multiple interactions EXP 6480464 deguelin inhibits the reaction [TNF protein results in increased expression of CFLAR mRNA] CTD PMID:22623043 CFLAR Human deguelin decreases expression EXP 6480464 deguelin results in decreased expression of CFLAR mRNA CTD PMID:22623043 CFLAR Human dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of CFLAR and Dexamethasone results in increased expression of CFLAR mRNA CTD PMID:21244764 and PMID:25047013 CFLAR Human dexamethasone multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CFLAR mRNA and Mifepristone inhibits the reaction [Dexamethasone results in increased expression of CFLAR] CTD PMID:21244764 and PMID:28628672 CFLAR Human dextran sulfate multiple interactions ISO Cflar (Mus musculus) 6480464 [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CFLAR protein more ... CTD PMID:25449198 CFLAR Human diallyl trisulfide decreases expression EXP 6480464 diallyl trisulfide results in decreased expression of CFLAR protein CTD PMID:25205294 CFLAR Human diallyl trisulfide increases expression EXP 6480464 diallyl trisulfide results in increased expression of CFLAR mRNA CTD PMID:34995734 CFLAR Human diarsenic trioxide decreases response to substance EXP 6480464 CFLAR protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:16105982 CFLAR Human diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of CFLAR mRNA more ... CTD PMID:16105982 more ... CFLAR Human diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of CFLAR mRNA CTD PMID:22521957 CFLAR Human diarsenic trioxide multiple interactions EXP 6480464 [Arsenic Trioxide co-treated with TNF protein] results in decreased expression of CFLAR protein more ... CTD PMID:17673311 and PMID:23082001 CFLAR Human diazinon increases expression EXP 6480464 Diazinon results in increased expression of CFLAR mRNA CTD PMID:27920530 CFLAR Human diazinon multiple interactions EXP 6480464 [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of CFLAR mRNA] more ... CTD PMID:27920530 CFLAR Human dibenz[a,h]anthracene decreases expression ISO Cflar (Mus musculus) 6480464 1 more ... CTD PMID:26377693 CFLAR Human diclofenac multiple interactions EXP 6480464 [Diclofenac co-treated with Hyaluronic Acid] results in decreased expression of CFLAR protein CTD PMID:20237495 CFLAR Human diclofenac affects expression EXP 6480464 Diclofenac affects the expression of CFLAR mRNA CTD PMID:24752500 CFLAR Human diethyl maleate decreases expression ISO Cflar (Rattus norvegicus) 6480464 diethyl maleate results in decreased expression of CFLAR mRNA CTD PMID:21161181 CFLAR Human dimethyl sulfoxide affects expression EXP 6480464 Dimethyl Sulfoxide affects the expression of CFLAR mRNA CTD PMID:24834073 CFLAR Human diosgenin decreases expression EXP 6480464 Diosgenin results in decreased expression of CFLAR protein CTD PMID:16331273 CFLAR Human diosgenin multiple interactions EXP 6480464 Diosgenin inhibits the reaction [TNF protein results in increased expression of CFLAR protein] CTD PMID:16331273 CFLAR Human dioxygen multiple interactions EXP 6480464 3 more ... CTD PMID:23452621 CFLAR Human dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of CFLAR mRNA CTD PMID:23452621 CFLAR Human dipyridamole multiple interactions EXP 6480464 Dipyridamole inhibits the reaction [Adenosine results in decreased expression of CFLAR mRNA alternative form] more ... CTD PMID:17303086 CFLAR Human diuron increases expression ISO Cflar (Rattus norvegicus) 6480464 Diuron results in increased expression of CFLAR mRNA CTD PMID:25152437 CFLAR Human dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 CFLAR Human doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of CFLAR protein CTD PMID:14601052 and PMID:15897917 CFLAR Human doxorubicin decreases expression ISO Cflar (Rattus norvegicus) 6480464 Doxorubicin results in decreased expression of CFLAR protein CTD PMID:15703961 CFLAR Human elemental selenium multiple interactions EXP 6480464 [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of CFLAR mRNA] and Selenium analog promotes the reaction [Diazinon results in increased expression of CFLAR mRNA] CTD PMID:27920530 CFLAR Human entinostat decreases expression EXP 6480464 entinostat results in decreased expression of CFLAR mRNA CTD PMID:26272509 and PMID:27188386 CFLAR Human entinostat multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFLAR mRNA CTD PMID:27188386 CFLAR Human enzalutamide multiple interactions ISO Cflar (Mus musculus) 6480464 enzalutamide promotes the reaction [lupeol results in decreased activity of CFLAR protein] and lupeol promotes the reaction [enzalutamide results in decreased activity of CFLAR protein] CTD PMID:37777120 CFLAR Human enzalutamide decreases activity ISO Cflar (Mus musculus) 6480464 enzalutamide results in decreased activity of CFLAR protein CTD PMID:37777120 CFLAR Human epoxiconazole decreases expression ISO Cflar (Mus musculus) 6480464 epoxiconazole results in decreased expression of CFLAR mRNA CTD PMID:35436446 CFLAR Human epoxomicin affects expression EXP 6480464 epoxomicin affects the expression of CFLAR protein alternative form CTD PMID:17510429 CFLAR Human etacrynic acid multiple interactions EXP 6480464 arsenic trioxide promotes the reaction [Ethacrynic Acid results in decreased expression of CFLAR protein] CTD PMID:23082001 CFLAR Human etacrynic acid decreases expression EXP 6480464 Ethacrynic Acid results in decreased expression of CFLAR protein CTD PMID:23082001 CFLAR Human ethanol increases expression ISO Cflar (Mus musculus) 6480464 Ethanol results in increased expression of CFLAR mRNA and Ethanol results in increased expression of CFLAR protein CTD PMID:19429258 and PMID:30319688 CFLAR Human ethyl methanesulfonate increases expression EXP 6480464 Ethyl Methanesulfonate results in increased expression of CFLAR mRNA CTD PMID:23649840 CFLAR Human etoposide increases expression EXP 6480464 Etoposide results in increased expression of CFLAR protein CTD PMID:14601052 CFLAR Human Evodiamine multiple interactions EXP 6480464 evodiamine inhibits the reaction [TNF protein results in increased expression of CFLAR protein] CTD PMID:15710601 CFLAR Human folic acid multiple interactions ISO Cflar (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CFLAR gene more ... CTD PMID:20938992 and PMID:22206623 CFLAR Human formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of CFLAR mRNA CTD PMID:23649840 CFLAR Human formaldehyde decreases expression EXP 6480464 Formaldehyde results in decreased expression of CFLAR mRNA CTD PMID:27905399 CFLAR Human genistein multiple interactions EXP 6480464 Genistein inhibits the reaction [Oxygen deficiency results in increased expression of CFLAR mRNA] CTD PMID:23452621 CFLAR Human gentamycin increases expression ISO Cflar (Rattus norvegicus) 6480464 Gentamicins results in increased expression of CFLAR mRNA CTD PMID:33387578 CFLAR Human gingerol multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [gingerol results in decreased expression of CFLAR protein] CTD PMID:25034532 CFLAR Human gingerol decreases expression EXP 6480464 gingerol results in decreased expression of CFLAR protein CTD PMID:25034532 CFLAR Human Glutathione ethyl ester multiple interactions EXP 6480464 S-ethyl glutathione inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in decreased expression of CFLAR protein modified form]] CTD PMID:25619640 CFLAR Human glycochenodeoxycholic acid increases expression ISO Cflar (Mus musculus) 6480464 Glycochenodeoxycholic Acid results in increased expression of CFLAR protein CTD PMID:25125499 CFLAR Human glycochenodeoxycholic acid multiple interactions ISO Cflar (Mus musculus) 6480464 Glycochenodeoxycholic Acid promotes the reaction [lysophosphatidylethanolamine analog results in increased expression of CFLAR protein] and lysophosphatidylethanolamine analog promotes the reaction [Glycochenodeoxycholic Acid results in increased expression of CFLAR protein] CTD PMID:25125499 CFLAR Human glycochenodeoxycholic acid multiple interactions EXP 6480464 Glycochenodeoxycholic Acid results in decreased expression of and results in increased phosphorylation of CFLAR protein CTD PMID:25125499 CFLAR Human glyphosate increases expression EXP 6480464 Glyphosate results in increased expression of CFLAR mRNA CTD PMID:31874349 CFLAR Human guggulsterone multiple interactions EXP 6480464 pregna-4 more ... CTD PMID:15322087 CFLAR Human hyaluronic acid multiple interactions EXP 6480464 [Diclofenac co-treated with Hyaluronic Acid] results in decreased expression of CFLAR protein CTD PMID:20237495 CFLAR Human hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of CFLAR protein CTD PMID:18603805 CFLAR Human hydrogen peroxide decreases expression ISO Cflar (Rattus norvegicus) 6480464 Hydrogen Peroxide results in decreased expression of CFLAR protein CTD PMID:16157298 CFLAR Human hydroquinone increases expression EXP 6480464 hydroquinone results in increased expression of CFLAR mRNA CTD PMID:31256213 CFLAR Human hydroxychloroquine decreases expression EXP 6480464 Hydroxychloroquine results in decreased expression of CFLAR mRNA and Hydroxychloroquine results in decreased expression of CFLAR protein CTD PMID:16734620 CFLAR Human hyperforin decreases expression EXP 6480464 hyperforin results in decreased expression of CFLAR protein CTD PMID:32485087 CFLAR Human ibrutinib decreases expression EXP 6480464 ibrutinib results in decreased expression of CFLAR mRNA CTD PMID:26254443 CFLAR Human idelalisib multiple interactions EXP 6480464 [FASLG protein co-treated with idelalisib] results in decreased expression of CFLAR protein more ... CTD PMID:31445927 CFLAR Human indole-3-methanol multiple interactions EXP 6480464 indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of CFLAR protein] CTD PMID:15811958 CFLAR Human indole-3-methanol decreases expression EXP 6480464 indole-3-carbinol results in decreased expression of CFLAR CTD PMID:16082211 CFLAR Human indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CFLAR mRNA and Indomethacin inhibits the reaction [LTA protein results in increased expression of CFLAR protein] CTD PMID:17873517 and PMID:28628672 CFLAR Human indometacin decreases expression ISO Cflar (Rattus norvegicus) 6480464 Indomethacin results in decreased expression of CFLAR mRNA CTD PMID:25972201 CFLAR Human irinotecan multiple interactions EXP 6480464 CFLAR protein alternative form inhibits the reaction [Irinotecan results in increased activity of TNFSF10 protein] CTD PMID:16373718 CFLAR Human irinotecan affects response to substance EXP 6480464 CFLAR protein affects the susceptibility to Irinotecan CTD PMID:16373718 CFLAR Human irinotecan decreases expression EXP 6480464 Irinotecan results in decreased expression of CFLAR protein CTD PMID:16373718 CFLAR Human jaceosidin decreases expression EXP 6480464 jaceosidin results in decreased expression of CFLAR mRNA and jaceosidin results in decreased expression of CFLAR protein CTD PMID:27729209 CFLAR Human jaceosidin multiple interactions EXP 6480464 CFLAR protein inhibits the reaction [jaceosidin results in increased cleavage of PARP1 protein] more ... CTD PMID:27729209 CFLAR Human L-methionine multiple interactions ISO Cflar (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CFLAR gene CTD PMID:20938992 CFLAR Human lactucin multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [lactucin results in decreased expression of CFLAR protein] more ... CTD PMID:34302634 CFLAR Human lipopolysaccharide multiple interactions ISO Cflar (Mus musculus) 6480464 [Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of CFLAR protein more ... CTD PMID:20850421 CFLAR Human lipopolysaccharide multiple interactions EXP 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CFLAR mRNA CTD PMID:35811015 CFLAR Human lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of CFLAR mRNA CTD PMID:35811015 CFLAR Human lipopolysaccharide increases expression ISO Cflar (Mus musculus) 6480464 Lipopolysaccharides results in increased expression of CFLAR mRNA CTD PMID:10975854 CFLAR Human lonafarnib multiple interactions EXP 6480464 lonafarnib inhibits the reaction [TNF protein results in increased expression of CFLAR protein] CTD PMID:15090542 CFLAR Human lupeol decreases activity ISO Cflar (Mus musculus) 6480464 lupeol results in decreased activity of CFLAR protein CTD PMID:37777120 CFLAR Human lupeol multiple interactions ISO Cflar (Mus musculus) 6480464 enzalutamide promotes the reaction [lupeol results in decreased activity of CFLAR protein] and lupeol promotes the reaction [enzalutamide results in decreased activity of CFLAR protein] CTD PMID:37777120 CFLAR Human LY294002 decreases expression EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of CFLAR protein and 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of CFLAR protein alternative form CTD PMID:12970779 more ... CFLAR Human lysophosphatidylethanolamine multiple interactions EXP 6480464 lysophosphatidylethanolamine analog inhibits the reaction [cobaltous chloride results in decreased expression of CFLAR mRNA] CTD PMID:25125499 CFLAR Human lysophosphatidylethanolamine increases expression ISO Cflar (Mus musculus) 6480464 lysophosphatidylethanolamine analog results in increased expression of CFLAR protein CTD PMID:25125499 CFLAR Human lysophosphatidylethanolamine increases expression EXP 6480464 lysophosphatidylethanolamine analog results in increased expression of CFLAR mRNA and lysophosphatidylethanolamine analog results in increased expression of CFLAR protein CTD PMID:25125499 CFLAR Human lysophosphatidylethanolamine multiple interactions ISO Cflar (Mus musculus) 6480464 Glycochenodeoxycholic Acid promotes the reaction [lysophosphatidylethanolamine analog results in increased expression of CFLAR protein] and lysophosphatidylethanolamine analog promotes the reaction [Glycochenodeoxycholic Acid results in increased expression of CFLAR protein] CTD PMID:25125499 CFLAR Human magnesium oxide multiple interactions EXP 6480464 [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of CFLAR mRNA] and Magnesium Oxide analog inhibits the reaction [Diazinon results in increased expression of CFLAR mRNA] CTD PMID:27920530 CFLAR Human manganese(II) chloride increases expression ISO Cflar (Rattus norvegicus) 6480464 manganese chloride results in increased expression of CFLAR mRNA CTD PMID:28801915 CFLAR Human medroxyprogesterone acetate multiple interactions EXP 6480464 [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CFLAR protein alternative form CTD PMID:16709600 CFLAR Human methotrexate increases expression EXP 6480464 Methotrexate results in increased expression of CFLAR mRNA CTD PMID:17696278 and PMID:21678067 CFLAR Human methylparaben decreases expression EXP 6480464 methylparaben results in decreased expression of CFLAR mRNA CTD PMID:31745603 CFLAR Human methylseleninic acid multiple interactions EXP 6480464 [2 more ... CTD PMID:18444175 CFLAR Human mifepristone multiple interactions EXP 6480464 Mifepristone inhibits the reaction [Dexamethasone results in increased expression of CFLAR] and Mifepristone inhibits the reaction [Rifampin inhibits the reaction [FAS protein results in increased expression of CFLAR protein modified form]] CTD PMID:12645856 and PMID:21244764 CFLAR Human mifepristone decreases expression ISO Cflar (Rattus norvegicus) 6480464 Mifepristone results in decreased expression of CFLAR mRNA CTD PMID:25972201 CFLAR Human Mitotane increases expression ISO Cflar (Rattus norvegicus) 6480464 Mitotane analog results in increased expression of CFLAR mRNA CTD PMID:23485034 CFLAR Human mono(2-ethylhexyl) phthalate multiple interactions ISO Cflar (Mus musculus) 6480464 [FASL affects the susceptibility to mono-(2-ethylhexyl)phthalate] which affects the expression of CFLAR protein CTD PMID:20100735 CFLAR Human N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [CSC-3436 results in decreased expression of CFLAR protein] more ... CTD PMID:25034532 more ... CFLAR Human N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal affects expression EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde affects the expression of CFLAR protein alternative form CTD PMID:17510429 CFLAR Human N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [(+)-JQ1 compound results in decreased expression of CFLAR protein] more ... CTD PMID:16951203 more ... CFLAR Human nickel atom increases expression EXP 6480464 Nickel results in increased expression of CFLAR mRNA CTD PMID:24768652 and PMID:25583101 CFLAR Human nickel dichloride affects expression ISO Cflar (Rattus norvegicus) 6480464 nickel chloride affects the expression of CFLAR mRNA CTD PMID:22546817 CFLAR Human nickel sulfate increases expression EXP 6480464 nickel sulfate results in increased expression of CFLAR mRNA CTD PMID:16780908 CFLAR Human ochratoxin A decreases expression ISO Cflar (Rattus norvegicus) 6480464 ochratoxin A results in decreased expression of CFLAR mRNA CTD PMID:18417182 CFLAR Human oxaliplatin affects response to substance EXP 6480464 CFLAR protein affects the susceptibility to oxaliplatin CTD PMID:16373718 CFLAR Human oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of CFLAR protein CTD PMID:16373718 CFLAR Human oxaliplatin multiple interactions EXP 6480464 CFLAR protein alternative form inhibits the reaction [oxaliplatin results in increased activity of TNFSF10 protein] CTD PMID:16373718 CFLAR Human ozone multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased expression of CFLAR mRNA and [Air Pollutants results in increased abundance of Ozone] which affects the expression of CFLAR mRNA CTD PMID:32845096 and PMID:35430440 CFLAR Human p-menthan-3-ol increases expression EXP 6480464 Menthol results in increased expression of CFLAR mRNA CTD PMID:26760959 CFLAR Human paclitaxel decreases response to substance EXP 6480464 CFLAR protein results in decreased susceptibility to Paclitaxel CTD PMID:16080463 CFLAR Human panobinostat multiple interactions EXP 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFLAR mRNA CTD PMID:27188386 CFLAR Human paracetamol affects expression ISO Cflar (Mus musculus) 6480464 Acetaminophen affects the expression of CFLAR mRNA CTD PMID:17562736 CFLAR Human paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CFLAR mRNA CTD PMID:21420995 and PMID:27761495 CFLAR Human pemetrexed decreases response to substance EXP 6480464 CFLAR results in decreased susceptibility to Pemetrexed CTD PMID:21726997 CFLAR Human pentanal decreases expression EXP 6480464 pentanal results in decreased expression of CFLAR mRNA CTD PMID:26079696 CFLAR Human Pentoxifylline multiple interactions EXP 6480464 [Pentoxifylline co-treated with TNFSF10 protein] results in decreased expression of CFLAR protein CTD PMID:20804743 CFLAR Human Pentoxifylline decreases expression EXP 6480464 Pentoxifylline results in decreased expression of CFLAR protein CTD PMID:18851957 CFLAR Human perfluorooctane-1-sulfonic acid multiple interactions ISO Cflar (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CFLAR mRNA CTD PMID:36331819 CFLAR Human perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of CFLAR mRNA CTD PMID:25868421 CFLAR Human pevonedistat affects expression EXP 6480464 pevonedistat affects the expression of CFLAR mRNA CTD PMID:24634471 CFLAR Human phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of CFLAR mRNA CTD PMID:19159669 CFLAR Human phenobarbital affects expression ISO Cflar (Mus musculus) 6480464 Phenobarbital affects the expression of CFLAR mRNA CTD PMID:23091169 CFLAR Human pirinixic acid decreases expression ISO Cflar (Mus musculus) 6480464 pirinixic acid results in decreased expression of CFLAR mRNA CTD PMID:18445702 and PMID:23811191 CFLAR Human potassium chromate decreases expression EXP 6480464 potassium chromate(VI) results in decreased expression of CFLAR mRNA CTD PMID:22079256 CFLAR Human potassium chromate multiple interactions EXP 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CFLAR mRNA CTD PMID:22079256 CFLAR Human progesterone increases expression ISO Cflar (Rattus norvegicus) 6480464 Progesterone results in increased expression of CFLAR mRNA CTD PMID:21770760 CFLAR Human protein kinase inhibitor decreases expression EXP 6480464 Protein Kinase Inhibitors results in decreased expression of CFLAR protein CTD PMID:21173233 CFLAR Human pyrethrins increases expression EXP 6480464 Pyrethrins results in increased expression of CFLAR mRNA CTD PMID:35321623 CFLAR Human quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of CFLAR mRNA and Quercetin results in decreased expression of CFLAR protein alternative form CTD PMID:18980244 and PMID:23727915 CFLAR Human quercetin multiple interactions EXP 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Quercetin results in decreased expression of CFLAR protein alternative form] CTD PMID:18980244 CFLAR Human rebaudioside A decreases expression EXP 6480464 rebaudioside A results in decreased expression of CFLAR mRNA CTD PMID:31655124 CFLAR Human resveratrol decreases expression ISO Cflar (Mus musculus) 6480464 resveratrol results in decreased expression of CFLAR protein CTD PMID:17872969 CFLAR Human resveratrol multiple interactions ISO Cflar (Mus musculus) 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of CFLAR mRNA] CTD PMID:31298478 CFLAR Human resveratrol decreases cleavage EXP 6480464 resveratrol results in decreased cleavage of CFLAR protein CTD PMID:18222423 CFLAR Human resveratrol multiple interactions EXP 6480464 [2 more ... CTD PMID:18444175 more ... CFLAR Human resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of CFLAR protein CTD PMID:20097879 CFLAR Human resveratrol increases expression ISO Cflar (Mus musculus) 6480464 resveratrol results in increased expression of CFLAR mRNA CTD PMID:16081268 CFLAR Human rifampicin multiple interactions EXP 6480464 Mifepristone inhibits the reaction [Rifampin inhibits the reaction [FAS protein results in increased expression of CFLAR protein modified form]] and Rifampin inhibits the reaction [FAS protein results in increased expression of CFLAR protein modified form] CTD PMID:12645856 CFLAR Human rifampicin increases expression EXP 6480464 Rifampin results in increased expression of CFLAR protein CTD PMID:11958592 CFLAR Human romidepsin multiple interactions EXP 6480464 [romidepsin co-treated with Bortezomib] results in decreased expression of CFLAR protein CTD PMID:18223231 CFLAR Human rubimaillin multiple interactions EXP 6480464 BCL2L1 protein inhibits the reaction [rubimaillin results in increased cleavage of CFLAR protein] CTD PMID:19716835 CFLAR Human rubimaillin increases cleavage EXP 6480464 rubimaillin results in increased cleavage of CFLAR protein CTD PMID:19716835 CFLAR Human S-(1,2-dichlorovinyl)-L-cysteine multiple interactions EXP 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CFLAR mRNA CTD PMID:35811015 CFLAR Human sarin increases expression EXP 6480464 Sarin results in increased expression of CFLAR mRNA CTD PMID:19522546 CFLAR Human SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 CFLAR Human selenium atom multiple interactions EXP 6480464 [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of CFLAR mRNA] and Selenium analog promotes the reaction [Diazinon results in increased expression of CFLAR mRNA] CTD PMID:27920530 CFLAR Human silicon dioxide increases expression ISO Cflar (Mus musculus) 6480464 Silicon Dioxide results in increased expression of CFLAR mRNA CTD PMID:19073995 CFLAR Human silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of CFLAR mRNA CTD PMID:34766707 CFLAR Human silver atom decreases expression ISO Cflar (Mus musculus) 6480464 Silver results in decreased expression of CFLAR mRNA CTD PMID:27131904 CFLAR Human silver(0) decreases expression ISO Cflar (Mus musculus) 6480464 Silver results in decreased expression of CFLAR mRNA CTD PMID:27131904 CFLAR Human simvastatin multiple interactions EXP 6480464 Simvastatin inhibits the reaction [TNF protein results in increased expression of CFLAR protein] CTD PMID:17277159 CFLAR Human simvastatin increases expression ISO Cflar (Mus musculus) 6480464 Simvastatin results in increased expression of CFLAR mRNA and Simvastatin results in increased expression of CFLAR protein CTD PMID:19262002 CFLAR Human simvastatin decreases expression EXP 6480464 Simvastatin results in decreased expression of CFLAR protein and Simvastatin results in decreased expression of CFLAR protein alternative form CTD PMID:18521906 and PMID:21910007 CFLAR Human sodium arsenate decreases expression ISO Cflar (Mus musculus) 6480464 sodium arsenate results in decreased expression of CFLAR mRNA CTD PMID:21795629 CFLAR Human sodium arsenite decreases expression ISO Cflar (Mus musculus) 6480464 sodium arsenite results in decreased expression of CFLAR mRNA CTD PMID:19822182 CFLAR Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of CFLAR mRNA CTD PMID:12016162 more ... CFLAR Human sorafenib decreases expression EXP 6480464 sorafenib results in decreased expression of CFLAR protein CTD PMID:17909059 CFLAR Human sorafenib increases degradation EXP 6480464 sorafenib results in increased degradation of CFLAR protein CTD PMID:20071162 CFLAR Human sorafenib multiple interactions EXP 6480464 [sorafenib co-treated with TNFSF10 protein] results in decreased expression of CFLAR protein more ... CTD PMID:17909059 and PMID:20071162 CFLAR Human steviol decreases expression EXP 6480464 steviol results in decreased expression of CFLAR mRNA CTD PMID:31655124 CFLAR Human stevioside decreases expression EXP 6480464 stevioside results in decreased expression of CFLAR mRNA CTD PMID:31655124 CFLAR Human succimer multiple interactions ISO Cflar (Mus musculus) 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CFLAR mRNA CTD PMID:21641980 CFLAR Human succimer multiple interactions EXP 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CFLAR mRNA CTD PMID:26378955 CFLAR Human sulindac sulfide decreases expression EXP 6480464 sulindac sulfide results in decreased expression of CFLAR protein CTD PMID:11912124 CFLAR Human tamoxifen multiple interactions EXP 6480464 [Tamoxifen co-treated with TNFSF10 protein] results in decreased expression of CFLAR protein modified form CTD PMID:17767197 CFLAR Human Tanshinone I increases expression EXP 6480464 tanshinone results in increased expression of CFLAR protein CTD PMID:26203587 CFLAR Human testosterone decreases expression ISO Cflar (Mus musculus) 6480464 Testosterone deficiency results in decreased expression of CFLAR mRNA CTD PMID:33848595 CFLAR Human tetrachloromethane increases expression ISO Cflar (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of CFLAR mRNA CTD PMID:17484886 CFLAR Human tetrachloromethane increases expression ISO Cflar (Rattus norvegicus) 6480464 Carbon Tetrachloride results in increased expression of CFLAR mRNA CTD PMID:31150632 CFLAR Human thalidomide decreases expression EXP 6480464 Thalidomide results in decreased expression of CFLAR protein CTD PMID:15986355 CFLAR Human thioacetamide decreases expression ISO Cflar (Rattus norvegicus) 6480464 Thioacetamide results in decreased expression of CFLAR mRNA CTD PMID:23411599 CFLAR Human titanium dioxide multiple interactions ISO Cflar (Mus musculus) 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of CFLAR mRNA] CTD PMID:31298478 CFLAR Human titanium dioxide increases expression ISO Cflar (Mus musculus) 6480464 titanium dioxide results in increased expression of CFLAR mRNA CTD PMID:31298478 CFLAR Human trichloroethene decreases expression ISO Cflar (Mus musculus) 6480464 Trichloroethylene results in decreased expression of CFLAR mRNA CTD PMID:19448997 CFLAR Human trichostatin A decreases expression EXP 6480464 trichostatin A results in decreased expression of CFLAR mRNA CTD PMID:28542535 CFLAR Human trimethyltin increases expression ISO Cflar (Mus musculus) 6480464 trimethyltin results in increased expression of CFLAR mRNA CTD PMID:21435392 CFLAR Human triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of CFLAR mRNA CTD PMID:37042841 CFLAR Human triptonide affects expression ISO Cflar (Mus musculus) 6480464 triptonide affects the expression of CFLAR mRNA CTD PMID:33045310 CFLAR Human troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of CFLAR protein CTD PMID:16820965 CFLAR Human troglitazone increases expression ISO Cflar (Mus musculus) 6480464 troglitazone results in increased expression of CFLAR mRNA CTD PMID:28973697 CFLAR Human tunicamycin increases expression ISO Cflar (Mus musculus) 6480464 Tunicamycin results in increased expression of CFLAR mRNA CTD PMID:17127020 CFLAR Human Tylophorine increases expression EXP 6480464 tylophorine analog results in increased expression of CFLAR mRNA CTD PMID:19284764 CFLAR Human ursodeoxycholic acid increases expression EXP 6480464 Ursodeoxycholic Acid analog results in increased expression of CFLAR protein CTD PMID:21146893 CFLAR Human valproic acid decreases expression ISO Cflar (Mus musculus) 6480464 Valproic Acid results in decreased expression of CFLAR mRNA CTD PMID:21427059 CFLAR Human valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of CFLAR mRNA CTD PMID:23179753 more ... CFLAR Human valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFLAR mRNA CTD PMID:27188386 CFLAR Human valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of CFLAR mRNA CTD PMID:25979313 CFLAR Human vinclozolin affects expression ISO Cflar (Rattus norvegicus) 6480464 vinclozolin affects the expression of CFLAR mRNA CTD PMID:19015723 CFLAR Human vincristine increases expression EXP 6480464 Vincristine results in increased expression of CFLAR mRNA CTD PMID:23649840 CFLAR Human vitamin E increases expression EXP 6480464 Vitamin E results in increased expression of CFLAR mRNA CTD PMID:19244175 CFLAR Human vorinostat multiple interactions EXP 6480464 [vorinostat co-treated with TNFSF10 protein] affects the localization of CFLAR protein more ... CTD PMID:16377638 and PMID:19643600 CFLAR Human vorinostat increases expression EXP 6480464 vorinostat results in increased expression of CFLAR protein modified form CTD PMID:17351739 CFLAR Human vorinostat decreases expression EXP 6480464 vorinostat results in decreased expression of CFLAR protein and vorinostat results in decreased expression of CFLAR protein modified form CTD PMID:15897598 more ... CFLAR Human zerumbone decreases expression EXP 6480464 zerumbone results in decreased expression of CFLAR mRNA CTD PMID:16007145 CFLAR Human zoledronic acid increases expression EXP 6480464 zoledronic acid results in increased expression of CFLAR mRNA CTD PMID:24714768
